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Summary
Components of the Fanconi anemia and homologous recombination pathways play a vital role in protecting
newly replicated DNA from uncontrolled nucleolytic degradation, safeguarding genome stability. Here we
report that histone methylation by the lysine methyltransferase SETD1A is crucial for protecting stalled
replication forks from deleterious resection. Depletion of SETD1A sensitizes cells to replication stress and
leads to uncontrolled DNA2-dependent resection of damaged replication forks. The ability of SETD1A to
prevent degradation of these structures is mediated by its ability to catalyze methylation on Lys4 of histone
H3 (H3K4) at replication forks, which enhances FANCD2-dependent histone chaperone activity.
Suppressing H3K4 methylation or expression of a chaperone-defective FANCD2 mutant leads to loss of
RAD51 nucleofilament stability and severe nucleolytic degradation of replication forks. Our work
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identifies epigenetic modification and histone mobility as critical regulatory mechanisms in maintaining
genome stability by restraining nucleases from irreparably damaging stalled replication forks.
Keywords: replication stress, histone methylation, replication fork replication, FANCD2, SETD1A,
BOD1L, lysine methyltransferase
Graphical Abstract
Introduction
To maintain genome stability during genome duplication, numerous cellular pathways have evolved to
detect and repair structures and/or lesions that impair DNA replication. One key response to compromised
replication (known as replication stress) involves the active reversal of stalled replication forks to form
4-way DNA junctions. This represents a critical step in stabilizing damaged forks (Neelsen and Lopes,
2015) and involves homologous recombination (HR) factors such as RAD51 (Wang et al., 2015, Zellweger
et al., 2015). However, despite the importance of fork reversal in protecting genome stability, it is also clear
that the regressed arms of reversed forks are highly susceptible to nucleolytic degradation (Thangavel et al.,
2015). Although controlled processing of these structures can help to maintain fork integrity and allow fork
restart, uncontrolled degradation of nascent DNA leads to severe genome instability (Quinet et al., 2017).
Components of the Fanconi anemia (FA) and HR pathways, including RAD51 (FANCR), FANCD2,
BRCA1 (FANCS), and BRCA2 (FANCD1), play a vital role in protecting nascent DNA at reversed
replication forks (Schlacher et al., 2011, Schlacher et al., 2012, Somyajit et al., 2015, Ying et al., 2012,
Zadorozhny et al., 2017). Moreover, the deleterious resection of replication forks observed in the absence
of these factors can be prevented by limiting fork reversal via depletion of “pro-reversal” factors; e.g.,
SMARCAL1 (Mijic et al., 2017, Taglialatela et al., 2017). However, despite intensive study, the
mechanisms by which cells protect nascent DNA still remain poorly understood. It is imperative that we
better understand these processes because restoring fork protection in tumor cells facilitates their ability to
evade chemotherapy and acquire drug resistance (Ray Chaudhuri et al., 2016).
Presently, it is unclear how reversed replication forks requiring protection are marked; this may involve the
presence of specific factors, post-translational modification of the replication machinery and/or surrounding
chromatin, and/or chromatin remodeling. In keeping with the premise that histone dynamics may play an
important role in this process, members of the SNF2 family of remodeling ATPases promote fork
degradation in the absence of protective factors (Taglialatela et al., 2017). Moreover, the fork protection
factor FANCD2 also remodels histones at sites of replication stress (Sato et al., 2012). Interestingly, several
chromatin modifiers have also been implicated in preventing fork degradation: the lysine methyltransferase
(KMT) EZH2 regulates recruitment of MUS81 to stalled forks (Rondinelli et al., 2017), whereas the KMTs
KMT2C/KMT2D (MLL2/3) enhance MRE11-dependent fork processing (Ray Chaudhuri et al., 2016). In
contrast, the yeast KMT Set1, a component of the evolutionarily conserved “complex proteins associated
Histone Methylation by SETD1A Protects Nascent DNA through the Nu... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039718/?report=printable
2 of 39 5/2/2019, 10:46 AM
with Set1p” (COMPASS) that catalyzes methylation of lysine 4 of histone H3 (H3K4), is required in the
response to replication stress (Faucher and Wellinger, 2010).
Recently, we identified BOD1L as a fork protection factor that protects nascent DNA from degradation by
DNA2 (Higgs et al., 2015, Higgs and Stewart, 2016). Here we demonstrate that BOD1L functionally
interacts with the KMT SETD1A and that cells lacking SETD1A phenocopy those depleted of BOD1L.
Furthermore, we show that SETD1A methylates H3K4 at stalled replication forks, which facilitates the
mobilization of histones by FANCD2 and prevents replication fork degradation. Compromising H3K4
methylation abrogates FANCD2-dependent histone chaperone activity, leads to fork degradation, and
mimics the inability of cells lacking SETD1A to recruit RAD51 to stalled forks. Our data therefore
establish that SETD1A-dependent histone methylation and subsequent histone remodeling protect stalled
forks from uncontrolled processing, thereby maintaining genome stability.
Results
BOD1L Interacts with SETD1A to Regulate Genome Stability Following Replication Stress
We recently identified BOD1L as a factor that protects stalled replication forks from degradation (Higgs
et al., 2015). Previous studies (van Nuland et al., 2013) have suggested that BOD1L forms complexes with
the KMTs SETD1A and SETD1B, two closely related members of the KMT2 family that catalyze H3K4
methylation (Bledau et al., 2014, Brici et al., 2017, Lee and Skalnik, 2005, Lee et al., 2007). This suggested
that SETD1A and/or SETD1B may function with BOD1L to regulate replication fork stability. We
therefore first sought to confirm these interactions before investigating any potential role of these enzymes
in fork protection. Interestingly, reciprocal immunoprecipitations confirmed that BOD1L interacts with
SETD1A, but not with SETD1B, as was suggested previously (van Nuland et al., 2013; Figure 1A).
The N-terminal region of BOD1L contains a region with sequence homology to the Shg1 component of the
yeast COMPASS complex (Figure S1A) (PFAM: 05205; http://pfam.xfam.org/family/PF05205) (Marchler-
Bauer et al., 2011, Roguev et al., 2001). We hypothesized that this “COMPASS-Shg1” domain may, by
analogy, mediate the interaction of BOD1L with the SETD1A complex. To assess this, we generated
glutathione S-transferase (GST)-tagged fragments of BOD1L spanning this domain or neighboring regions
and analyzed their ability to interact with SETD1A. These experiments revealed that a fragment of BOD1L
containing this COMPASS-Shg1 domain was necessary and sufficient to mediate interaction with SETD1A
but not with SETD1B (Figure S1B).
To analyze the functional consequences of this interaction, we depleted HeLa cells of BOD1L, SETD1A, or
SETD1B, either alone or in combination (Figure 1B), and exposed them to mitomycin C (MMC), which
induces DNA interstrand crosslinks (ICLs). Notably, depletion of SETD1A or BOD1L alone exquisitely
hypersensitized cells to MMC (Figure 1C). Moreover, cells lacking SETD1A exhibited elevated
chromosomal damage (Figures 1D, 1E, and S1C) and increased micronucleus formation after treatment
with MMC (Figure 1F), indicating a critical role for this KMT in maintaining genome stability after
replication damage. In all cases, loss of SETD1A alone or alongside BOD1L was comparable with BOD1L
depletion, consistent with these two factors residing within the same protein complex. In contrast, depletion
of SETD1B had no effect on cellular sensitivity to replication stress (Figure 1), in keeping with our
interaction data, although we cannot completely exclude a role of this enzyme in regulating genome
stability. Moreover, cells lacking SETD1A or BOD1L, but not SETD1B or BOD1 (a BOD1L paralog),
were unable to suppress replication origin firing after MMC exposure (Figure S1D), a characteristic of
BOD1L deficiency (Higgs et al., 2015). Together with our previous data demonstrating that depletion of
BOD1 had no effect on MMC cellular sensitivity (Higgs et al., 2015), these observations are consistent
with a model in which BOD1L/SETD1A and BOD1/SETD1B form functionally distinct KMT complexes.
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SETD1A and BOD1L Suppress BLM/FBH1 to Stabilize RAD51 and Prevent DNA2-
Dependent Degradation of Nascent DNA
Preventing aberrant replication fork resection is essential for genome integrity during replication stress. The
RAD51 recombinase plays a crucial role in protecting stalled forks from such degradation (Schlacher et al.,
2011, Schlacher et al., 2012, Zadorozhny et al., 2017, Zellweger et al., 2015); indeed, our previous studies
demonstrated that BOD1L suppresses degradation of stalled replication forks by stabilizing RAD51 at
these sites (Higgs et al., 2015). To investigate whether SETD1A functioned in a similar fashion, we first
analyzed DNA resection in cells depleted of BOD1L, SETD1A, or SETD1B, using phosphorylation of
RPA2 on S4/S8 as a well-established marker of resected DNA. Interestingly, levels of MMC-induced
RPA2-P-S4/8 were substantially elevated upon loss of BOD1L or SETD1A but not SETD1B (Figures 1G,
2A, and 2B), consistent with increased generation of single-stranded DNA (ssDNA). Moreover, similar to
BOD1L, SETD1A was required to recruit or stabilize RAD51 at stalled forks upon exposure to either
MMC or hydroxyurea (HU) (Figures 2C and 2D). Co-depletion of SETD1A and BOD1L had no additional
effect on RPA/RPA2-P-S4/8 or RAD51 focus formation, again suggesting that these factors act together (
Figures 2B–2G). Next, using 5-ethynyl-2'-deoxyuridine (EdU)-Click coupled to proximity ligation (PLA)
(Petruk et al., 2012, Taglialatela et al., 2017), we analyzed whether the association of RAD51with nascent
DNA was affected by loss of SETD1A. In agreement with our previous data, SETD1A depletion
significantly decreased the levels of RAD51 on newly replicated DNA after HU exposure (Figure 2H).
Given the importance of RAD51 in suppressing deleterious fork processing, we next assessed whether
SETD1A was required to protect nascent DNA at replication forks. To this end, we used a well-
characterized fork protection assay (Schlacher et al., 2011) to monitor the stability of nascent DNA during
prolonged replication arrest by HU. Loss of SETD1A, but not SETD1B, increased the degradation of HU-
stalled forks, apparent as a decreased iododeoxyuridine (IdU):chlorodeoxyuridine (CldU) ratio (Figure 3A;
Table S1), supporting our hypothesis that SETD1A and SETD1B are functionally distinct. Moreover, the
fork degradation observed upon BOD1L loss was comparable with that arising from SETD1A depletion (
Figure 3B; Table S1). Because fork remodeling enzymes such as SMARCAL1 catalyze fork reversal and,
thus, provide a substrate for nucleolytic degradation in the absence of protective factors (Kolinjivadi et al.,
2017), we investigated whether loss of SMARCAL1 suppressed fork resection observed upon SETD1A
loss. Indeed, depletion of this annealing helicase reduced nascent strand degradation in cells lacking
SETD1A (Figure 3C; Table S1). Together, this suggests that SETD1A-BOD1L prevent the resection of
reversed replication forks.
Recent studies have suggested that other members of the KMT2 family (KMT2C [MLL3] and KMT2D
[MLL2]) promote nascent strand degradation in the absence of BRCA2 (Ray Chaudhuri et al., 2016).
However, although we also observed that depletion of KMT2C/KMT2D rescued fork stability in the
absence of BRCA2, this was not the case when these factors were co-depleted in combination with
SETD1A (Figures 3D–3F; Table S1). Moreover, in stark contrast to cells lacking SETD1A, loss of
KMT2C/D alone had no effect on fork stability after HU. These data reinforce the notion that different
KMT2 enzymes have diverse functions during replication stress.
Factors that regulate the stability of RAD51 filaments, such as PARI, BLM, FBH1, and the RAD51
paralogs, also play vital roles in maintaining replication fork stability (Mochizuki et al., 2017, Somyajit
et al., 2015). Previous work has demonstrated that uncontrolled BLM/FBH1 activity can destabilize
RAD51 nucleofilaments at stalled replication forks, leading to fork degradation (Higgs et al., 2015, Higgs
and Stewart, 2016, Leuzzi et al., 2016). We therefore predicted that SETD1A may also counteract the
activities of these two anti-recombinases to stabilize RAD51 at stalled forks. To investigate this, we co-
depleted SETD1A and BLM (Figure S2A), exposed the cells to MMC, and monitored RPA S4/S8
phosphorylation and RAD51 focus formation. Strikingly, loss of BLM reduced MMC-induced RPA S4/S8
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phosphorylation (Figure S2B) and restored HU- and MMC-induced RAD51 focus formation in the absence
of SETD1A (Figures S2C and S2D). Moreover, depletion of either FBH1 or BLM abrogated the
degradation of nascent DNA observed in cells lacking SETD1A (Figure S2E; Table S1).
Because BOD1L, RAD51, and the FA pathway are crucial for suppressing fork resection by DNA2 (Higgs
et al., 2015, Karanja et al., 2014, Liu et al., 2016), we assessed whether the over-resection observed in the
absence of SETD1A was dependent on DNA2 or whether other nucleases implicated in fork resection were
also involved. In keeping with our previous observations in cells lacking BOD1L (Higgs et al., 2015), co-
depletion of DNA2, but not EXO1 or MRE11, suppressed the degradation of HU-stalled forks in the
absence of SETD1A (Figure S2F; Table S1). Therefore, SETD1A and BOD1L act together to stabilize
RAD51 on nascent DNA by restraining the anti-recombinase functions of BLM/FBH1, protecting damaged
replication forks from DNA2-dependent resection.
The Catalytic Activity of SETD1A Is Required for Fork Protection
Previous studies have demonstrated that the methyltransferase activity of SETD1A toward H3K4 is
mediated by its C-terminal N-SET (COMPASS component N-Su(var)3-9, Enhancer-of-zeste, Trithorax
domain) and SET catalytic domains, whereas interactions with WDR82, RNA, and RNA polymerase II
(Pol II) occur via the N-terminal RRM domain (Lee and Skalnik, 2008, Luciano et al., 2017, Schlichter and
Cairns, 2005). To examine which of these domains is required for fork protection by SETD1A, we
established U-2-OS cell lines in which endogenous SETD1A could be depleted with small interfering RNA
(siRNA), and either full-length (FL) FLAG-tagged SETD1A or variants lacking the RRM (ΔRRM) or
catalytic SET (ΔSET) domains could be inducibly expressed (Figures S3A and S3B). Strikingly, the
genome instability (Figure 4A), defective RAD51 focus formation (Figures 4B and 4C), and increased fork
degradation (Figure 4D) observed in the absence of endogenous SETD1A were all restored following
induced expression of FL and ΔRRM SETD1A, but not the catalytically inactive ΔSET variant. This
suggests that the role for SETD1A in resolving replication stress is independent of its ability to regulate
transcription. This contrasts with recent publications suggesting that SETD1A functions within the DNA
damage response (DDR) in hematopoietic cells to regulate the transcription of a subset of DDR genes, in
part via association with CDK12/Cyclin K (Arndt et al., 2018, Hoshii et al., 2018). To address this
disparity, we therefore examined the protein levels of DDR genes identified to be deregulated in the
absence of SETD1A. These analyses revealed little or no change in the expression of these DDR proteins
upon SETD1A depletion (Figure S3C). Moreover, and in support of a transcription-independent role of
SETD1A in regulating fork protection, depletion of Cyclin K had no effect on nascent DNA degradation of
HU-stalled forks (Figures S3D and S3E) despite its apparent role in SETD1A-dependent transcription
(Hoshii et al., 2018). Our findings therefore demonstrate that the catalytic methyltransferase activity of
SETD1A is necessary for its role in fork protection. Importantly, this function is unlikely to be mediated
through regulation of DDR gene transcription or via an interaction with Cyclin K.
SETD1A Catalyzes H3K4 Methylation at Replication Forks to Prevent Deleterious Fork
Processing
Because the catalytic activity of SETD1A protects nascent DNA from degradation, we next wanted to
assess the effect of depleting SETD1A or its closely related paralog, SETD1B, on H3K4 methylation.
Interestingly, depletion of these separate KMT components from HeLa cells led to a significant, albeit
different, reduction in levels of global H3K4 mono-methylation (H3K4me1), with depletion of SETD1A or
SETD1B having effects comparable with loss of BOD1L or BOD1, respectively (Figure 5A), a finding
recapitulated in two independent DT40 BOD1L knockout clones (Figure S4A). These data suggest that,
although SETD1A and SETD1B KMT complexes both target the same residue on histone H3, their loss has
a differential effect on total levels of H3K4 methylation.
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Given our findings, we next investigated whether SETD1A catalyzed H3K4 methylation specifically at
stalled or reversed replication forks during replication stress. We first used isolation of proteins on nascent
DNA (iPOND) coupled with mass spectrometry to assess protein abundance on newly replicated DNA.
This approach demonstrated that components present in all KMT2 complexes (WDR5, RBBP5, and
ASH2L) and those only found in the SETD1A and SETD1B KMT complexes (WDR82 and HCFC1) all
associate with nascent DNA and HU-stalled forks (Figure S4B). Moreover, SETD1A, but not SETD1B,
was also detected at these sites, albeit infrequently. We next analyzed whether mono-methylated H3K4 at
forks was affected by replication stress or by loss of SETD1A or SETD1B using EdU-PLA. This revealed
that the association of H3K4me1 with nascent DNA increased upon exposure to HU in a manner dependent
on SETD1A (Figure 5B). Importantly, this was not due to any global changes in histone abundance after
HU exposure, since levels of H3 on nascent DNA were unaffected by either HU or SETD1A loss
(Figure S4C). Moreover, this effect was specific to H3K4me1 because the levels of H3K4me3 at similar
sites were markedly less affected by SETD1A loss (Figure 5C). These data suggest that SETD1A catalyzes
H3K4me1 at stalled replication forks.
To directly investigate the effect of H3K4 methylation on replication fork resection, we disrupted the
balance of steady-state methylation of H3K4 by creating stable HeLa cell lines expressing wild-type (WT)
GFP-tagged histone H3.1 or a K4A mutant. Expression of these variants in addition to endogenous H3.1
had no overt effects on cell cycle progression, regardless of the presence of replication stress (Figure S4D).
Next, we exposed these cells to prolonged HU treatment and then assayed for loss of fork protection.
Strikingly, mutation of Lys4 of H3 recapitulated the elevated fork degradation observed in cells lacking
BOD1L or SETD1A (Figure 5D). Notably, loss of SETD1A in cells expressing the H3K4A mutant had no
additional effect on fork resection (Figure 5E), further reinforcing the hypothesis that this KMT complex
mediates fork protection via H3K4 methylation.
To analyze whether H3K4 methylation affected the stability of RAD51 at stalled or damaged replication
forks, we next monitored RAD51 focus formation in these cells. Strikingly, the formation of MMC- and
HU-induced RAD51 foci was severely compromised by expression of H3.1-GFP K4A but not by its WT
counterpart (Figures 5F and S4E). This was recapitulated in two separate cell clones and could not be
accounted for by any alterations in RAD51 or H3-GFP protein expression (Figure S4F). Furthermore,
expression of the K4A variant significantly decreased the levels of RAD51 on nascent DNA after HU
exposure (Figure 5G), resulted in MMC hyper-sensitivity (Figure 5H), and increased the levels of MMC-
induced chromosomal damage (Figures 5I andS4G). Consistent with a model in which BOD1L, SETD1A,
and H3K4 methylation act together to protect RAD51 from the destabilizing activity of BLM, depletion of
BLM in cells expressing H3.1-GFP K4A restored RAD51 focus formation (Figure S4H) and abrogated
fork degradation (Figure S4I). Finally, depletion of DNA2 in cells expressing H3.1-GFP K4A also restored
fork stability (Figure S4J), in line with a role for H3K4 methylation in preventing fork processing by this
exonuclease.
Together, these data suggest that the failure of cells lacking SETD1A to stabilize RAD51 at stalled
replication forks and the subsequent inability to protect these structures from degradation are intimately
linked to a defect in H3K4 methylation on nascent DNA.
H3.1 Methylation Suppresses CHD4-Mediated Fork Degradation
To investigate the mechanisms underlying methylation-dependent fork protection, we first examined the
involvement of methyl-histone “reader” proteins. Members of the chromodomain helicase DNA-binding
(CHD) family play important roles in replication stress, and their activities or chromatin localization are
intimately linked with H3K4 methylation status. In particular, the H3K4 methyl-binding protein CHD1 is
implicated in DNA resection and RAD51 loading (Kari et al., 2016, Shenoy et al., 2017, Sims et al., 2005),
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whereas the nucleosome remodeling deacetylase (NuRD) component and tri-methylated lysine 9 of histone
H3 (H3K9me3) reader CHD4 is negatively regulated by H3K4 methylation and promotes nascent DNA
degradation in BRCA2-deficient cells (Guillemette et al., 2015, Ray Chaudhuri et al., 2016, Watson et al.,
2012).
We therefore predicted that SETD1A-dependent fork protection may involve either of these remodelers. To
examine this, we co-depleted SETD1A and either CHD1 or CHD4 and examined the effect on ssDNA
prevalence, RAD51 focus formation, and replication fork and genome stability following exposure to
MMC. Interestingly, depletion of CHD4, but not CHD1, reduced the elevated RPA focus formation
observed upon SETD1A loss (Figures S5A and S5B). However, abrogation of CHD4 expression in the
absence of SETD1A did not restore RAD51 focus formation (Figure 6A), suggesting that CHD4 does not
act to destabilize RAD51 nucleofilaments in the absence of H3K4 methylation. Nevertheless, depletion of
CHD4 in cells lacking SETD1A restored replication fork stability (Figures 6B and 6C), rescued MMC
hyper-sensitivity (Figure S5C), and reduced MMC-induced genome instability (Figure 6D), consistent with
a role for CHD4 in promoting nascent strand degradation in the absence of SETD1A. In keeping with the
known role for H3K4 methylation in negatively regulating CHD4, loss of SETD1A increased CHD4
localization on nascent DNA upon HU treatment (Figure 6E), despite having no effect on H3K9me3 levels
at these sites (Figure S5D). In further support, depletion of CHD4 (but not CHD1) from cells expressing
H3.1-GFP K4A also restored fork stability to normal levels (Figure S5E). Together, these findings
demonstrate that CHD4-mediated fork degradation underlies the genome instability arising in cells lacking
SETD1A and that H3K4 methylation protects genome stability in part by restricting the accessibility of
CHD4 to reversed forks.
The Histone Chaperone Activity of FANCD2 Acts Downstream of Histone Methylation to
Protect Stalled Forks
It is well-established that FANCD2 plays multiple roles in protecting against replication stress, including
the ability to suppress DNA2-dependent degradation of nascent DNA in the absence of BRCA1/2 (Kais
et al., 2016, Karanja et al., 2014, Schlacher et al., 2012). Given the functional overlap with SETD1A, and
because we have previously demonstrated that FANCD2 interacts with BOD1L (Higgs et al., 2015), we
postulated that BOD1L, SETD1A, and FANCD2 may function together. In agreement, co-depletion of
FANCD2 and SETD1A had no additional effect on the extent of fork resection compared with loss of the
individual genes alone (Figure 7A; Table S1), and depletion of BLM alleviated the fork resection observed
in cells lacking FANCD2 (Figure S6A; Table S1). Furthermore, loss of FANCD2 did not further increase
nascent DNA degradation in cells expressing GFP-H3.1 K4A (Figure 7B). Together, this provides strong
evidence that SETD1A, H3K4 methylation, and FANCD2 function within the same pathway to prevent
deleterious resection of stalled forks.
FANCD2 also possesses a histone chaperone activity that is critical for ICL repair in vitro and in vivo (Sato
et al., 2012). Given the links between SETD1A, H3 methylation, and FANCD2, we postulated that the
BOD1L/SETD1A complex may also be required for histone chaperoning upon replication stress. To assess
this, we depleted BOD1L, SETD1A, or SETD1B from cells expressing WT H3.1-GFP and analyzed the
mobility of GFP-tagged H3.1 before and after MMC exposure using fluorescence recovery after
photobleaching (FRAP). Previous data demonstrated that, in the absence of FANCD2, the recovery kinetics
of H3.1-GFP were perturbed specifically in the presence of replication stress (Sato et al., 2012). Strikingly,
the mobility of H3.1-GFP after MMC treatment was also impaired in the absence of SETD1A or BOD1L
(but not SETD1B) (Figure S6B) in a manner similar to cells lacking FANCD2. Furthermore, co-depletion
of FANCD2 alongside either BOD1L or SETD1A had no significant additional effect on H3.1-GFP
mobility (Figures S6C and S6D), suggesting that these three proteins function together to remodel
chromatin after replication stress. To assess whether SETD1A and FANCD2 were specifically required for
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the mobility of newly synthesized histones, we next made use of the SNAP-tagged H3.1 system (Adam
et al., 2013). These analyses revealed that SETD1A and FANCD2 also promote the mobility or deposition
of new H3.1 histones after HU exposure (Figures 7C and S6E).
Given that loss of BOD1L/SETD1A perturbs histone mobility, we postulated that impaired H3K4me may
also negatively affect this process. We therefore analyzed histone mobility by FRAP in cells expressing the
H3.1-GFP K4A variant. When compared with WT H3.1-GFP, mutation of Lys4 lead to impaired H3.1-GFP
mobility specifically after replication stress (Figures 7D and S6F), a finding recapitulated in both cell
clones (Figure S6G). Together, these data suggest that H3K4 methylation promotes H3 mobility in the
presence of replication damage. In agreement, depletion of either BOD1L or SETD1A had no additional
effect on H3.1-GFP K4A mobility (Figure S6H), indicating that this KMT complex promotes histone
mobility through its ability to methylate H3K4.
Intriguingly, these data also suggest that stalled replication forks may be protected from degradation by the
chaperone activity of FANCD2. To address this possibility, we made use of DT40 cells expressing either
WT chFANCD2, the mono-ubiquitylation-deficient chFANCD2-K563R mutant, or the histone chaperone-
defective mutant chFANCD2-R305W (Sato et al., 2012; Figure S7A). We then compared the ability of
these variants to prevent fork degradation after prolonged HU treatment. Notably, loss of the histone
chaperone function of FANCD2 compromised its ability to protect nascent DNA from processing (Figure 7
E; Table S1). Moreover, pharmacological inhibition of DNA2 (Liu et al., 2016), but not MRE11, in cells
expressing chFANCD2-R305W restored fork stability (Table S1), suggesting that the histone chaperone
function of FANCD2 protects against DNA2-dependent fork degradation. Finally, and in keeping with a
role for the histone chaperone activity of FANCD2 in promoting RAD51-dependent fork protection, the
destabilization of MMC-induced RAD51 nucleofilaments in human cells lacking FANCD2 (measured by
FRAP) (Sato et al., 2016) was not restored by expression of the histone chaperone-defective R302W
mutant (Figures 7F and S7B).
To further delineate the link between the histone chaperone activity of FANCD2 and H3K4 methylation,
we examined whether binding of FANCD2 to H3 was affected by H3K4 methylation or whether FANCD2
was necessary for SETD1A activity. Interestingly, although loss of FANCD2 expression had no effect on
H3K4me1 levels (Figure S7C), we observed a small but reproducible increase in the binding of FANCD2
(either from extracts or using recombinant protein) to H3 peptides or proteins that were mono-methylated
on K4 (Figures S7D–S7G), suggesting that H3K4me1 may modulate FANCD2 binding, albeit mildly. In
agreement, loss of SETD1A had a mild effect on the recruitment of FANCD2 to damaged chromatin
(Figure S7H), but not to nascent DNA (Figure S7I). Although we did not observe a marked effect of
H3K4me1 on FANCD2-histone binding, our data suggest that this modification might, in part, facilitate
recruitment of FANCD2 to sites of replication stress.
Combined, our data demonstrate that, during replication stress, H3K4 methylation by SETD1A protects
replication forks from over-resection by limiting CHD4 localization and by enhancing FANCD2-dependent
histone chaperone activity. Subsequent histone mobility protects stalled replication forks from degradation
by promoting RAD51-dependent fork protection (Figure 7G). In the absence of H3K4 methylation or
SETD1A, histone mobility is reduced, destabilizing RAD51 at damaged forks. These forks then undergo
deleterious resection, partly mediated via the unrestrained activity of CHD4, giving rise to severe genome
instability.
Discussion
Although many factors required to stabilize damaged replication forks have been identified, it remains to be
determined how post-translational modification of chromatin helps to govern this process. Here we have
demonstrated that the KMT SETD1A plays an integral role in preventing degradation of nascent DNA at
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reversed forks. Critically, we have shown that SETD1A-mediated H3K4 methylation is required for this
protection and for the stabilization of RAD51 at reversed forks. As a consequence, cells depleted of
SETD1A or expressing a mutant of H3 unable to be methylated on Lys4, fail to stabilize RAD51, are
unable to protect nascent DNA from degradation by DNA2, and exhibit increased genome instability after
exposure to replication stress. Moreover, because the fork degradation in cells lacking SETD1A or
expressing H3K4A can be rescued by depletion of the anti-recombinase BLM, this strongly suggests that
H3K4 methylation is inherently linked to maintaining RAD51 nucleofilament stability.
SETD1A and SETD1B Are Functionally Distinct KMTs
Although the COMPASS KMT Set1 and histone H3K4 methylation have previously been linked to
resistance to replication stress in yeast (Faucher and Wellinger, 2010), the roles of the mammalian
COMPASS homologs SETD1A and SETD1B in this process have so far not been examined. Here we
demonstrate that, although these two KMTs both target H3K4 for methylation, only SETD1A is required to
protect cells against replication stress. Indeed, in contrast to loss of SETD1A, depletion of SETD1B does
not confer MMC hyper-sensitivity at the cellular level and does not lead to replication fork instability (
Figures 1, 2, and 3). This functional divergence is likely linked to their ability to bind specific Shg1-like
proteins, our data (Figures 1 and S1), combined with previous analyses, strongly suggest that SETD1A
functionally interacts with BOD1L, whereas SETD1B interacts with BOD1 (Hein et al., 2015, van Nuland
et al., 2013). Moreover, BOD1, like SETD1B, plays no discernible role in the cellular response to
replication stress (Higgs et al., 2015). This is in agreement with a recent publication describing a functional
cytoplasmic SETD1B-BOD1 complex (Wang et al., 2017). Interestingly, because BOD1 modulates the
activity of specific PP2A regulatory subunits at kinetochores during mitosis (Porter et al., 2007, Porter
et al., 2013), SETD1B-dependent histone methylation may also play a role in this process.
We speculate that, because both BOD1 and BOD1L contain a COMPASS-Shg1 domain (Marchler-Bauer
et al., 2011, van Nuland et al., 2013), which, in the case of BOD1L, likely mediates its interaction with
SETD1A (Figure S1B), it is these subunits of the SET1-containing complexes that regulate the distribution
and/or function of the respective catalytic KMT. Because BOD1L is a target for ataxia telangiectasia
mutated/ATR-dependent (ATM/ATR-dependent) phosphorylation (Matsuoka et al., 2007), we hypothesize
that such damage-induced modification may modulate the recruitment and/or activity of the
BOD1L/SETD1A complex at stalled replication forks. In addition, our data suggest that, despite their
shared ability to methylate H3K4, SETD1A and SETD1B may methylate chromatin at distinct
environments or in response to different stimuli. In support of this notion, SETD1A and SETD1B function
in a non-redundant manner during embryogenesis and the embryonic lethality resulting from loss of either
KMT occur at different stages of development (Bledau et al., 2014).
Mechanisms for Epigenetic Modifications in Regulating Fork Stability
Our data, when combined with observations assessing the effect of the H3K27 KMT EZH2 (Rondinelli
et al., 2017) and the PTIP-containing MLL2/3 KMT complex (Ray Chaudhuri et al., 2016) on replication
fork stability, are consistent with the hypothesis that epigenetic modifications control the recruitment and/or
activity of factors that regulate fork stability. In keeping with this prediction, we demonstrate that H3K4
methylation regulates the localization of the chromodomain helicase DNA-binding protein CHD4 (Figure 6
). Interestingly, our finding that CHD4 loss prevents nascent DNA degradation in the absence of SETD1A
without restoring RAD51 recruitment (Figures 6A–6C) in a manner similar to observations in BRCA2
mutant cells (Guillemette et al., 2015, Ray Chaudhuri et al., 2016) suggests that CHD4 may either promote
replication fork reversal or modulate the local chromatin environment to allow nucleases access to the
damaged fork. Although the precise contribution of CHD4 to fork degradation in the context of SETD1A
deficiency remains to be elucidated, in cells lacking BRCA1/2, this pro-resection activity of CHD4 occurs
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through dysregulation of RAD18-dependent translesion synthesis (TLS). It is currently unclear whether a
similar mechanism occurs in BOD1L/SETD1A-depleted cells.
In addition to SETD1A and SETD1B, the KMT2 family of H3K4 methyltransferases also contains the
myeloid/lymphoid (MLL) subfamily of enzymes (KMT2A–KMT2D). Recent studies have proposed a role
for murine Mll3 and Mll4 (human KMT2C [MLL3] and KMT2D [MLL2] respectively) in promoting fork
resection in the absence of BRCA2 (Ray Chaudhuri et al., 2016). These studies suggested that H3K4
methylation promotes fork degradation upon loss of BRCA1 or BRCA2 by recruiting MRE11 to stalled or
reversed forks. In contrast, we have demonstrated that SETD1A-dependent H3K4 methylation protects
reversed forks from resection by promoting RAD51-dependent fork stability. It is also clear that SETD1A
depletion does not promote nascent strand degradation in the absence of BRCA2 and that it is functionally
distinct from KMT2C/D (Figure 3). On face value, it is difficult to reconcile why different KMT complexes
targeting H3K4 would have opposing roles at damaged replication forks. However, it is apparent that all 6
members of the KMT2 family of methyltransferases are not functionally redundant (Bledau et al., 2014,
Duncan et al., 2015). Moreover, the timing, localization, and cellular context of specific nucleosomes being
targeted for H3K4 methylation is likely to have very different outcomes. Interestingly, only loss of
SETD1A (and not SETD1B or KMT2C/D) on a WT genetic background allows increased fork resection (
Figure 3), indicating a primary constitutive role for this KMT2 family member in preventing fork
degradation. In contrast, the enzymatic activity of the PTIP-associated methyltransferases (KMT2C/D)
only appears to be required when fork stability has already been compromised; e.g., in the absence of
BRCA2 (Ray Chaudhuri et al., 2016; Figure 3).
Several hypotheses arise from these observations: first, SETD1A may regulate multiple different processes
required to stabilize a damaged fork; for example, stabilizing RAD51 nucleofilaments, suppressing anti-
recombinase activity, and methylating H3 at reversed forks. Second, the context of the damaged fork might
dictate which KMT is utilized to modify the nascent chromatin surrounding the fork. In this respect, it is
conceivable that SETD1A and KMT2C/D could target histone H3 within different regions of the genome
undergoing DNA replication (Calo and Wysocka, 2013, Duncan et al., 2015) or differentially methylate the
histone variants H3.1 and H3.3 at damaged forks, depending on the composition of the chromatin
undergoing replication; i.e., whether it is a transcriptionally active or inactive region. Finally, specific
epigenetic changes surrounding damaged forks may dictate which KMT is recruited. For example, H2B
mono-ubiquitylation in yeast and humans by the Bre1 or RNF20/40 ubiquitin ligases potentiates H3K4
methylation by promoting recruitment of the Set1-COMPASS complexes via their Swd2 subunit (human
WDR82) (Hung et al., 2017, Wood et al., 2005, Wu et al., 2008). Because the MLL KMT complexes lack
WDR82 (van Nuland et al., 2013), H2B mono-ubiquitylation would provide a high degree of specificity
and selectivity between the different KMT2 complexes. Furthermore, because the KMT2 complexes differ
in their associated cofactors, it is plausible that these complex-specific subunits (e.g., BOD1L and PTIP)
may bind alternative epigenetic marks to convey further selectivity.
Methylation-Enhanced Nucleosome Mobility Is Required for Fork Protection
For the first time, our findings illustrate that histone methylation is intimately linked to nucleosome
mobility at damaged forks and that this is required to prevent degradation of nascent DNA. At present, it is
unclear how H3K4 methylation regulates FANCD2-dependent histone chaperoning. It is possible that
SETD1A-dependent histone methylation may modulate the accessibility of chromatin to FANCD2,
allowing histones to be mobilized. Alternatively, H3K4 methylation may promote the recruitment and/or
binding of co-factors vital to promote FANCD2-dependent nucleosome remodeling. Nevertheless, our
working model places SETD1A-dependent H3K4 methylation as a major regulatory epigenetic
modification that permits FANCD2 to mobilize histones onto the regressed arm of a reversed fork (Figure 7
G), protecting the 3′ end of the RAD51 nucleofilament from the anti-recombinase activities of BLM. This
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siRNA Transfections
is entirely in keeping with the finding that fork degradation in cells lacking FANCD2 is restored by co-
depletion of BLM and that the histone chaperone activity of FANCD2 is required for RAD51
nucleofilament stability (Figures 7 and S7). Furthermore, this model predicts that movement of histones
onto or near reversed forks is a vital mechanism to protect their integrity and suggests that other factors
able to promote histone mobility in similar situations may also be involved in protecting nascent DNA.
In summary, our findings reveal the importance of the methylation and subsequent mobility of histones in
protecting nascent DNA from nucleolytic degradation. Our data further reinforce the notion that epigenetic
modifications of chromatin surrounding stalled forks play a critical role in governing the
recruitment/activity of pro- and anti-resection factors and highlight the importance of context-dependent
histone lysine methylation in maintaining genome stability.
STAR★Methods
Key Resources Table
Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to, and will be fulfilled by,
the Lead Contact, Professor Grant Stewart (g.s.stewart@bham.ac.uk).
Experimental Model and Subject Details
U-2-OS cells (ATCC) were cultured in McCoys 5A medium,
supplemented with 10% FBS and penicillin/streptomycin. HeLa cells (ATCC) were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum (FCS) (Life Technologies) and
penicillin/streptomycin.
U-2-OS-FLAG-SETD1A FL, ΔSET and ΔRRM inducible cell lines were generated by Flp recombinase–
mediated integration using U-2-OS-Flp-In T-REx host cells transfected with pcDNA5/FRT-FLAG-
SETD1A FL, ΔSET or ΔRRM, together with pOG44. Transfected cells were selected and expanded for
testing, cultured as above in the presence of 10% Tet-free FBS (Lonza), and SETD1A variant expression
was induced with doxycycline (Sigma-Aldrich).
The generation of HeLa cells expressing both H3.1-GFP WT and mCherry-PCNA was described
previously (Sato et al., 2012). The HeLa cells expressing either H3.1-GFP K4A or WT H3.1-GFP were
generated using PiggyBac Transposon Vector System (System Biosciences). After cloning the H3.1-GFP
K4A or WT H3.1-GFP sequence into PB533A-2 vector, the resulting plasmid was cotransfected into HeLa
cells with PiggyBac Transposase vector (PB210PA-1) using FuGene HD (Promega). The cells were then
cultured in 1 mg/ml G418 (Nacalai Tesque) to select clones stably expressing either H3.1-GFP K4A or WT
H3.1-GFP. The creation of stable U-2-OS-GFP-RAD51 cells was described in Sato et al. (2016). HeLa and
U-2-OS cells used for FRAP analysis were cultured in Dulbecco’s modified Eagle’s medium (High
Glucose; Nacalai Tesque), supplemented with 10% fetal bovine serum (JRH Bioscience) and
penicillin/streptomycin.
Wild-type and FANCD2 mutant DT40 cell lines are described in Sato et al. (2012) and were cultured in
RPMI medium supplemented with 10% FCS, 1% chicken serum (Sigma Aldrich) and 10 μM
β-mercaptoethanol (Life Technologies).
Method Details
siRNAs were purchased from Dharmacon as SMARTpool, and all siRNA
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transfections were performed with 100 nM of siRNA duplexes using Oligofectamine (Life Technologies) or
Lipofectamine2000 (Life Technologies). Whenever siRNAs were combined, the total concentration was
kept at 100 nM. An siRNA targeting lacZ (CGUACGCGGAAUACUUCGdTdT) or Negative Control Hi
GC (Life Technologies; for GFP-RAD51 analysis) was used as “Control siRNA.” SETD1A 3′ UTR siRNA
was from QIAGEN. See Key Resources Table for siRNA sequences.
HU and MMC were from Sigma Aldrich, and were used as indicated in
Figure Legends. dNTP analogs EdU, CldU and IdU were from Sigma Aldrich, and were used as denoted.
Thymidine was from Sigma Aldrich. Mirin (100 μM) was from Calbiochem, and C5 (DNA2 inhibitor)
(20 μM) was obtained from Judith Campbell (Liu et al., 2016).
Constructs encoding pcDNA5/FRT-FLAG-SETD1A FL, ΔSET and ΔRRM variants were obtained
from David Skalnik (Lee and Skalnik, 2005). pSNAPm-H3.1 was obtained from Geneviève Almouzni
(Adam et al., 2013). Plasmids encoding WT or chaperone-dead (R302W) mCherry-FANCD2 are described
in Sato et al. (2012). GST-tagged BOD1L fragments were amplified by PCR from human cDNA and
cloned into the SalI-NotI restriction sites of pGEX-3X. Fragments 1 and 2 correspond to amino acids 1-600
and 500-1000 of BOD1L respectively. See Key Resources Table for primer sequences.
For colony survival assays, siRNA-transfected HeLa or HeLa-H3.1-GFP cells
were plated at low density, and exposed to increasing doses of MMC. Colonies were fixed and stained after
14 days with 2% methylene blue (Sigma Aldrich) in 50% ethanol. Data are expressed as a percentage
survival normalized to non-treatment control for each siRNA.
DNA fibers were carried out as described previously (Higgs et al., 2015). For quantification of
replication structures, cells were treated with MMC (50 ng/ml) for 24 hr prior to analog labeling, and at
least 250 structures were counted per experiment. For fork resection experiments, cells were pulse-labeled
with CldU and IdU for 20 min each before a 5 hr exposure to 4 mM HU, and at least 200 replication forks
were analyzed per experimental condition. For fork resection experiments in DT40 cells, cells were pulse-
labeled as above, spun down in media containing 4 mM HU and then exposed to HU for 5 hr as above. The
lengths of red or green labeled tracts were measured using ImageJ (National Institutes of Health;
https://imagej.nih.gov/ij/) and arbitrary length values were converted into micrometers using the scale bars
created by the microscope. Mean tract ratios, SEM values and statistical analyses for all DNA fiber analysis
can be found in Table S1.
iPOND was performed on HEK293T cells as described (Dungrawala et al., 2015). Briefly, light and
heavy labeled cells were pulse-labeled with EdU, incubated with 3 mM HU for 4 hr where indicated, mixed
prior to the click reaction, and DNA-protein complexes were captured with streptavidin-coupled beads.
Samples were separated by SDS-PAGE, excised, reduced with DTT and carbamidomethylated, and then
destained. Polypeptides were digested with trypsin and analyzed by mass spectrometry using a Q Exactive
mass spectrometer in conjunction with MaxQuant. Plots are amalgamated from published log2 abundance
data for the conditions denoted.
EdU-PLA to detect proteins at nascent DNA was performed as described
(Taglialatela et al., 2017), with minor modifications. Briefly, cells were pulsed with 10 μM EdU for 10 min
cells before being permeabilised with nuclear extraction buffer (10 mM PIPES, 20 mM NaCl, 3 mM
MgCl , 300 mM sucrose, 0.5% Triton X-100). Where appropriate, cells were exposed to 4 mM HU for 5 hr
before pre-extraction. Cells were then fixed with 3.6% paraformaldehyde for 10 min at room temperature
and blocked with ADB (Antibody Dilution Buffer; 3% BSA in PBS) overnight at 4°C. EdU was conjugated
to biotin by incubating cells in Click reaction buffer for 1 hr at room temperature containing 10 μM Diazo-
biotin Azide, 10 mM sodium ascorbate, and 1 mM copper (II) sulfate in PBS. Following the Click reaction,
cells were blocked in ABD before incubated in primary antibodies before proceeding with proximity
2
Histone Methylation by SETD1A Protects Nascent DNA through the Nu... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039718/?report=printable
12 of 39 5/2/2019, 10:46 AM
Flow Cytometry
Metaphase Spreads
Immunofluorescence, Microscopy, and Image Analysis
SNAP Labeling of Histones
Fluorescence Recovery after Photobleaching (FRAP)
ligation using a Duolink Detection Kit in combination with anti-Mouse PLUS and anti-Rabbit MINUS
PLA Probes (Sigma Aldrich) according to the manufacturer’s instructions. Cells were imaged as below and
the number of PLA signals per nuclei quantified.
HeLa cells were harvested, fixed in 70% ethanol at −20°C for 1 hr, and permeabilised
with 0.25% Triton X-100 for 15 min at 4°C. Cells were then washed twice with 1% BSA in PBS, and
stained with 25 μg/ml propidium iodide containing 0.1 mg/ml RNase A. Cells were analyzed using an
Accuri flow cytometer (BDBiosciences) in conjunction with CFlowplus software. Data represent that
obtained from at least 30,000 cells.
Chromosomal aberrations and radial chromosomes were scored in Giemsa stained
metaphase spreads. For chromosome aberrations, demecolcine (Sigma) was added 3-4 hr prior to
harvesting at a final concentration of 0.2 μg/ml. Cells were harvested by trypsinization, subjected to
hypotonic shock for 1 hr at 37°C in 0.3 M sodium citrate and fixed in 3:1 methanol:acetic acid solution.
Cells were dropped onto acetic acid humidified slides, stained for 15 min in Giemsa-modified (Sigma)
solution (5% v/v in H2O) and washed in water for 5 min.
HeLa, U-2-OS, HeLa-H3.1-GFP and U-2-OS-
FLAG-SETD1A cells were grown on glass coverslips. Cells were washed with PBS twice before fixation.
In all cases, cells were permeabilised with nuclear extraction buffer for 5 min on ice prior to fixation in
3.6% paraformaldehyde for 10 min at room temperature. After fixation, cells were washed with PBS three
times and then blocked with ADB for 1 hr at 4°C. Cells were incubated with primary antibody (diluted in
ADB) for 1 hr at room temperature, washed with PBS and then counterstained with Alexa Fluor-conjugated
secondary antibodies (diluted in ADB) for 1 hr at room temperature. Cells were then washed twice with
ADB and coverslips were mounted onto glass slides with Vectashield mounting agent containing 0.4 μg/ml
DAPI (Vectashield). Images were taken using a Nikon Eclipse Ni microscope equipped with a 60X oil lens,
and were acquired and analyzed using Elements v4.5 software (Nikon). For RPA intensity analyses, the
intensity of nuclear foci was quantified for each cell using ImageJ. See Key Resources Table for details of
antibodies used.
U-2-OS cells were grown on glass coverslips, transfected with siRNA,
incubated for 48 hr, and transfected with pSNAPm-H3.1 using FuGene HD. 24 hr post DNA transfection,
pre-existing SNAP-H3.1 was labeled with SNAP-cell 505 star (New England Biolabs) according to the
manufacturer’s instructions (‘pulse’). Alternatively, pre-existing H3.1 was quenched by incubating cells
with SNAP-cell Block (New England Biolabs), and then cells were pulsed as described above (‘quench-
pulse’), or released into 2 mM HU for 2 hr before newly synthesized SNAP-H3.1 was labeled as above
(‘quench-HU-pulse’). In all cases, cells were fixed with ice cold methanol for 10 min before being mounted
onto glass slides. Images were taken as above, and the intensity of nuclear SNAP signal was quantified for
each cell using ImageJ.
FRAP was performed as previously described
(Sato et al., 2012, Sato et al., 2016). HeLa cells expressing both H3.1-GFP and mCherry-PCNA were
grown on a glass-bottom dish (Mat-tek), transfected with siRNA, incubated for 48 h, and treated with
MMC (50 ng/ml) for 12-24 hr. FRAP was then performed using an FV-1000 with a PlanApoN 60x OSC
(NA = 1.4) oil-immersion objective lens (Olympus) at 37°C under 5% CO2. Three confocal images were
collected (800x800 pixels, zoom 2, scan speed 2 μs/pixel, Kalman filtration for four scans, pinhole 800 μm,
0.1% 488-nm laser transmission, and 20% 543-nm laser transmission). Afterward, one half of PCNA-foci
positive nucleus was bleached using 75% transmission of 488 nm and 100% of 515 nm (three iterations),
and images were obtained using the original setting at 5 min intervals. The fluorescence intensities of the
unbleached and bleached areas and background were measured using ImageJ 1.46r software
(https://imagej.nih.gov/ij/). After background subtraction, the relative intensity of the bleached area to the
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Western Blotting, Pull-downs, and Immunoprecipitations
unbleached area in each time point was calculated and normalized to the average intensity before
bleaching. H3.1-GFP K4A was analyzed by the same procedure with or without mitomycin C (50 ng/ml).
For GFP-RAD51 FRAP, U-2-OS cells expressing GFP-RAD51 were grown on a glass-bottom dish,
transfected with siRNA, incubated for 24 hr, and transfected with either the RNAi-resistant mCherry-
FANCD2 or mCherry-FANCD2 (R302W) vector using FuGene HD. The next day, cells were then treated
with doxycycline (1-10 ng/ml) and MMC (100 ng/ml) for 12-24 hr, as described previously (Sato et al.,
2016). FRAP was then performed using an FV-1000 confocal microscopy with a PlanApoN 60x OSC
(NA = 1.4) oil-immersion objective lens (Olympus) at 37°C under 5% CO2. Six z-slice images (0.5 μm
intervals) containing GFP-RAD51 foci were collected (256 × 32 pixels, scan speed 2 μs/pixel, zoom 12,
pinhole 800 μm, 0.1% 488-nm laser transmission, and 20% 543-nm laser transmission). Afterward, a single
GFP-RAD51 focus was photobleached using 100% transmission of 488-nm laser (1 iteration for each
z-plane), and images were collected using the original settings at 1.89 s intervals for 100 s. The 2D
maximum z-projection was reconstructed, and the fluorescence intensities of the bleached area were
measured using ImageJ 1.46r software. After the background subtraction, the intensity was normalized to
the initial intensity before bleaching.
For western blotting, whole cell extracts were
obtained by lysis in UTB buffer (8 M Urea, 50 mM Tris, 150 mM β-mercaptoethanol, protease inhibitor
cocktail (Roche)). Cell extracts were sonicated, clarified by centrifugation, and protein concentration was
determined by Bradford Assay (Bio-Rad). Polypeptides were separated by SDS-PAGE, transferred onto
nitrocellulose membrane, incubated with primary antibody overnight, followed by HRP-linked secondary
antibody for 1hr at room temperature. The signal was detected using ECL western blotting substrate (GE
Healthcare).
For immunoprecipitations, HeLa nuclear cells extracts (Cilbiotech) were clarified by centrifugation at
44,000 x g, immunoprecipitated with 5 μg of the indicated antibody or IgG for 3 hr at 4°C. After further
clarification, immune complexes were isolated using protein-A Sepharose (GE Healthcare), and analyzed
by immunoblotting as above.
For GST pull-downs, 1 μg of affinity-purified GST or GST fusion protein was incubated with pre-clarified
HeLa nuclear cells extract for 3 hr at 4°C. Fusion proteins and binding partners were isolated using
glutathione Sepharose (GE Healthcare) and analyzed as above. See Key Resources Table for details of
antibodies used.
For histone peptide pull-downs, lyophilized biotinylated peptides (Active Motif) were resuspended and
immobilised onto Strepavidin Agarose beads (Sigma Aldrich) as described in Wysocka (2006) at a final
concentration of 250 ng/ul. Immobilised peptides were then incubated with clarified HeLa nuclear cells
extracts for 3 hr at 4°C before being washed with buffer D (100 mM KCl, 20 mM HEPES pH 7.9, 20% v/v
glycerol, 0.2 mM EDTA, 0.2% Triton X-100, protease inhibitors). Alternatively, immobilised peptides were
incubated with 100 ng of purified human FANCD2 (Sato et al., 2012, Takahashi et al., 2014) in binding
buffer (20 mM Tris pH 7.5, 150 mM NaCl, 300 mM sucrose, 1 mM MgCl , protease inhibitors) for 3 hr at
4°C. Bound protein was washed with buffer D. In both cases, peptide binding partners were analyzed by
immunoblotting as above.
For histone pull-downs, lyophilised recombinant biotinylated H3 or H3K4me1 (EPL) (Active Motif) were
resuspended in 25 mM Tris pH 7.5, 150 mM NaCl, 5% glycerol at a final concentration of 1 μg/ul, and then
incubated with 100 ng of purified human FANCD2 in binding buffer for 3 hr at 4°C. Histones were isolated
with Strepavidin Agarose beads for a further 3 hr at 4°C, washed as above and analyzed by
immunoblotting.
2
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Quantification and Statistical Analysis
Differences in survival assays were analyzed by two-way ANOVA. Statistical differences in all other cases
were determined by Student’s t test, except for fork asymmetry, fork resection and EdU-PLA data, which
were analyzed by Mann-Whitney rank sum test. Statistical differences denoted in the Figures were
determined by comparison to the relevant control-treated samples unless otherwise indicated. In all cases:
 = p < 0.05;  = p < 0.01;  = p < 0.001.
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Table S1. Average Values, SEM, and p Values for Fork Degradation Experiments, Related to
Figures 3, 4, 5, 6, and 7:
The average tract length ratios (IdU:CldU) and SEM for all nascent strand degradation experiments
are collated, along with the p values obtained for each condition relative to relevant control cells
(denoted with ‘-’). ND, not determined.
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Figure 1
Open in a separate window
BOD1L Acts with SETD1A to Maintain Genome Stability during Replication Stress
(A) HeLa nuclear cell extracts were subjected to immunoprecipitation with the denoted antibodies, and inputs and
immunoprecipitates were analyzed by immunoblotting. White lines denote removal of irrelevant lanes.
(B) HeLa cells were transfected with the indicated siRNAs for 72 hr and whole-cell extracts (WCEs) were analyzed by
immunoblotting.
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(C) HeLa cells were transfected as above, exposed to the indicated doses of MMC, and left for 14 days, and colonies were
stained with methylene blue and counted.
(D and E) Cells from (C) were exposed to 50 ng/mL MMC for 20 hr and treated with colcemid for a further 4 hr.
Chromosomal damage (D) and radial chromosome formation (E) were enumerated by light microscopy after Giemsa
staining. Representative images are shown in Figure S1.
(F) Cells from (C) were treated with MMC and left for 24 hr, and micronucleus formation was assessed by fluorescence
microscopy.
(G) Cells from (C) were exposed to MMC for the indicated times, and WCE was analyzed by immunoblotting.
The plots in (C)–(E) represent mean data ± SEM from 3 independent experiments. p < 0.05, p < 0.01, and p < 0.001.
See also Figure S1.
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Figure 2
Open in a separate window
SETD1A Prevents Excessive ssDNA Formation after Replication Stress by Stabilizing RAD51
(A–C) HeLa cells were transfected with the indicated siRNAs for 72 hr; exposed to 50 ng/mL MMC for 24 hr;
immunostained with antibodies to RPA2 (A), phospho-RPA2 S4/S8 (B), or RAD51 (C). Focus formation was analyzed by
fluorescence microscopy.
(D) Cells from (A) were exposed to 4 mM HU for 5 hr and immunostained with antibodies to RAD51, and focus formation
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was analyzed as above.
(E) Nuclear fluorescence intensity of cells from (A) was quantified using ImageJ. Lines denote mean values.
(F) Double-positive (RPA- and phospho-RPA2) cells from (A) and (B) were enumerated and are displayed as a percentage
of total cells.
(G) The mean percentage of cells from (C) and (D) exhibiting RAD51 foci was enumerated as above.
(H) Quantification of PLA signals between EdU and RAD51 in U-2-OS cells transfected with the indicated siRNAs.
Where denoted, cells were exposed to 4 mM HU for 5 hr (as shown in the schematic). The mean ± SD of the number of
biotin/biotin PLA signal-positive cells (below) indicates the number of S phase cells in each condition.
The plots in (E)–(H) represent mean data ± SEM from 3 independent experiments. Scale bars, 10 μm. p < 0.05, p <
0.01, and p < 0.001. See also Figure S2.
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Figure 3
Open in a separate window
SETD1A Suppresses Fork Degradation after Replication Stress
(A–F) U-2-OS cells were transfected with control siRNA or those targeting: SETD1A and SETD1B (A); BOD1L and
SETD1A (B); SETD1A and SMARCAL1 (C); SETD1A and BRCA2 (D); SETD1A, BRCA2, and either KMT2C (E), or
KMT2D (F). 72 hr post transfection, cells were pulsed for 20 min each with CldU and IdU and exposed to 4 mM HU for
5 hr (as in the schematic). DNA was visualized with antibodies to CldU and IdU, and tract lengths were calculated. Plots
denote average ratios of IdU:CldU label length from 3 independent experiments; arrows indicate mean ratios. Plots in (E)
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and (F) amalgamate data from the same experiments. See also Table S1.
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Figure 4
Open in a separate window
The KMT Activity of SETD1A Is Required to Protect Nascent DNA from Degradation
(A) U-2-OS cell lines bearing inducible full-length (FL) SETD1A or mutants lacking the RRM (ΔRRM) or N-SET and
SET (ΔSET) domains were transfected with the indicated siRNAs for 48 hr, exposed to 1 μg/mL doxycycline for 24 hr
where denoted, and then exposed to 50 ng/mL MMC for a further 24 hr. Micronucleus formation was quantified by
fluorescence microscopy.
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(B and C) Cells from (A) were immunostained with antibodies to RAD51, and focus formation was analyzed by
fluorescence microscopy (B). Representative images are shown in (C). Scale bar, 20 μm.
(D) Cells from (A) were treated as described in Figure 3; arrows denote mean ratios.
Plots represent mean data ± SEM from 3 independent experiments. p < 0.05, p < 0.01, and p < 0.001. See also
Figure S3 and Table S1.
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Figure 5
Open in a separate window
SETD1A-Mediated H3K4 Methylation Is Required for Fork Protection
(A) HeLa cells were transfected with the indicated siRNAs for 72 hr, and WCEs were analyzed by immunoblotting.
(B and C) Quantification of PLA signals between EdU and H3K4me1 (B) or H3K4me3 (C) in U-2-OS cells transfected
with the indicated siRNAs. Cells were exposed to 4 mM HU for 5 hr where denoted.
(D) Stable HeLa cells expressing WT H3.1-GFP or a K4A mutant (clone D1) were treated as described in Figure 3, and
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average IdU:CldU ratios were calculated (denoted by an arrow).
(E) Cells from (D) were transfected with the indicated siRNAs and treated as above.
(F) Cells from (D) were exposed to 50 ng/mL MMC for 24 hr or 4 mM HU for 5 hr and immunostained with antibodies to
RAD51, and focus formation was analyzed by fluorescence microscopy. Scale bar, 20 μm.
(G) Quantification of PLA signals between EdU and RAD51 in cells from (D). Where denoted, cells were exposed to
4 mM HU for 5 hr.
(H) Cells from (D) were exposed to the indicated doses of MMC and left for 14 days, and colonies were stained with
methylene blue and enumerated.
(I) Cells from (D) were exposed to 50 ng/mL MMC for 20 hr and treated with colcemid, and the incidence of
chromosomal damage was analyzed by Giemsa staining and light microscopy.
The plots in all cases represent mean data ± SEM from 3 independent experiments. p < 0.05, p < 0.01, and p <
0.001. See also Figure S4 and Table S1.
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Figure 6
Open in a separate window
H3K4 Methylation by SETD1A Protects against CHD4-Mediated Fork Degradation
(A) U-2-OS cells were transfected with the indicated siRNAs for 72 hr, exposed to 50 ng/mL MMC for 24 hr, and
immunostained with antibodies to RAD51, and focus formation was analyzed by fluorescence microscopy. Representative
images are shown (right). Scale bars, 10 μm.
(B and C) Cells were transfected with control siRNA or those targeting SETD1A and CHD1 (A) or SETD1A and CHD4
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(B), exposed to HU, and treated as described in Figure 3. Plots in (B) and (C) amalgamate data from the same experiments;
arrows indicate mean ratios.
(D) Micronucleus formation in cells from (A) was analyzed by fluorescence microscopy.
(E) Quantification of PLA signals between EdU and RAD51 in U-2-OS cells transfected with the indicated siRNA. Where
denoted, cells were exposed to 4 mM HU for 5 hr.
In all cases, plots represent mean data ± SEM from 3 independent experiments. p < 0.05 and p < 0.001. See also
Figure S5 and Table S1.
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Figure 7
Open in a separate window
SETD1A and FANCD2 Promote H3 Mobility to Protect Fork Integrity
(A) U-2-OS cells were transfected with the indicated siRNAs and treated as in Figure 3. Arrows indicate mean ratios.
(B) Stable HeLa cells expressing WT H3.1-GFP or a K4A mutant (clone D1) were transfected with the indicated siRNAs
and treated as above.
(C) U-2-OS cells from (A) were transfected with SNAP-tagged H3.1 and analyzed to reveal levels of pre-existing SNAP-
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H3.1 (Pulse), background fluorescence (Quench-Pulse), and new H3.1 after a 2-hr release into HU (Quench-HU-Pulse).
Cells were analyzed by fluorescence microscopy, and fluorescence intensity per nucleus was quantified using ImageJ.
(D) Stable HeLa cells expressing WT H3.1-GFP or a K4A mutant (clone D1) were left untreated or exposed to MMC for
24 hr and analyzed by FRAP.
(E) WT DT40 cells or FANCD2  cells expressing the indicated GFP-tagged chFANCD2 variants were treated as
described in Figure 3. Arrows indicate mean ratios.
(F) Stable U-2-OS-GFP-RAD51 cells were co-transfected with the indicated siRNA and plasmids encoding either WT or
chaperone-dead (R302W) mCherry-FANCD2 and exposed to MMC, and the mobility of GFP-RAD51 was analyzed by
FRAP.
(G) Model for the role of SET1A-dependent H3K4 methylation in protecting stalled replication forks. Upon fork reversal
during replication stress, H3K4me1 by SETD1A acts to restrict CHD4 localization and promote FANCD2-dependent
histone mobility. This chaperone activity is vital to stabilize RAD51 nucleofilaments, preventing nucleolytic degradation
of stalled forks by DNA2.
The plots in (D) and (F) represent mean ± SD relative fluorescence intensities from n = 21–26 and 25–48 cells,
respectively. p < 0.05. See also Figures S6 and S7 and Table S1.
−/−
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
BOD1L Grant Stewart; Higgs et al.,
2015
N/A
SETD1A Bethyl Labs Cat# A300-289A; RRID:
AB_263413
SETD1B Bethyl Labs Cat# A302-281A; RRID:
AB_1850180
BOD1 Jason Swedlow; Porter et al.,
2013
N/A
H3 (detection of GFP-H3) Active Motif Cat# 39763; RRID: AB_2650522
H3 Abcam Cat# ab1791; RRID: AB_302613
H3K4me1 Abcam Cat# ab8895; RRID: AB_306847
H3K4me2 Millipore Cat# 04-790; RRID: AB_10562969
H3K4me3 Abcam Cat# ab8580; RRID: AB_306649
H3K9me3 Abcam Cat# ab8898; RRID: AB_306848
RPA Millipore Cat# NA18; RRID: AB_10682810
P-RPA (S4/8) Bethyl Labs Cat# A300-245A; RRID:
AB_210547
RAD51 Millipore Cat# PC130; RRID: AB_2238184
γH2AX Millipore Cat# 05-636; RRID: AB_309864
H2A Millipore Cat# 07-146; RRID: AB_11212920
CldU (BrdU) Bio-Rad Cat# OBT0030G; RRID:
AB_609567
IdU (BrdU) Becton Dickinson Cat# 347580; RRID: AB_10015219
FANCD2 Santa Cruz Cat# sc-20022; RRID: AB_2278211
FANCD2 Novus Cat# NB100-182; RRID:
AB_10002867
Actin Sigma-Aldrich Cat# A5316; RRID: AB_476743
BLM Bethyl Labs Cat# A300-110A; RRID:
AB_2064794
FLAG Sigma-Aldrich Cat# F1804; RRID: AB_262044
PCNA Santa Cruz Cat# sc-56; RRID: AB_628110
MRE11 Abcam Cat# ab397; RRID: AB_2145241
GFP Roche Cat# 11814460001; RRID:
AB_390913
CHD1 Bethyl Labs Cat# A301-218A; RRID:
AB_890568
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REAGENT or RESOURCE SOURCE IDENTIFIER
CHD4 Bethyl Labs Cat# A301-082A; RRID:
AB_873002
Cyclin K Bethyl Labs Cat# A301-939A; RRID:
AB_1547934
GST Thermo Fisher Scientific Cat# 700775; RRID: AB_2532343
Biotin (rabbit) Bethyl Labs Cat# A150-109A; RRID: AB_67327
Biotin (mouse) Jackson ImmunoResearch Cat# 200-002-211; RRID:
AB_2339006
Alexa Fluor anti-mouse 594 Thermo Fisher Scientific Cat# A11032; RRID: AB_141672
Alexa Fluor anti-rabbit 488 Thermo Fisher Scientific Cat# A11070; RRID: AB_142134
Alexa Fluor anti-rat 555 Thermo Fisher Scientific Cat# A21434; RRID: AB_141733
Alexa Fluor anti-mouse 488 Thermo Fisher Scientific Cat# A11029; RRID: AB_138404
Anti-rabbit HRP Agilent Cat# P0399; RRID: AB_2617141
Anti-mouse HRP Agilent Cat# P0447; RRID: AB_2617137
Anti-goat HRP Agilent Cat# P0449; RRID: AB_2617143
Anti-rabbit HRP (Reliablot) Bethyl Labs Cat# WB120
IgG Agilent Cat# X0903
Bacterial and Virus Strains
BL21-CodonPlus (DE3)-RP-X Competent
cells
Agilent Cat# 260275
Chemicals, Peptides, and Recombinant Proteins
Mitomycin C Sigma-Aldrich Cat# M4287
Hydroxyurea Sigma-Aldrich Cat# H8627
Doxycycline Cayman Chemical Cat# 14422
Mirin Calbiochem Cat# 475954-10MG
DNA2 inhibitor (C5) Judith Campbell; Liu et al.,
2016
N/A
CldU Sigma-Aldrich Cat# C6891
IdU Sigma-Aldrich Cat# I7125
EdU Life Technologies Cat# 11590926
Oligofectamine Life Technologies Cat# 2252011
Lipofectamine2000 Life Technologies Cat# 11668-019
FugeneHD Promega Cat# E2311
Entellan Mounting Media Millipore Cat# HX61088761
Vectashield (with DAPI) Vectorlabs Cat# H-1200
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REAGENT or RESOURCE SOURCE IDENTIFIER
Propidium Iodide Sigma-Aldrich Cat# P4864
Protein A Sepharose GE Healthcare Cat# 17-0780-01
Streptavidin Agarose Sigma-Aldrich Cat# S1638
Glutathione Sepharose GE Healthcare Cat# 17-0756-01
Diazo-Biotin Azide Stratech Cat# CLK-1041-10-JEN
Thymidine Sigma-Aldrich Cat# T1895
Fluoroshield Sigma-Aldrich Cat# F6182
Histone H3 Peptide - biotinylated Active Motif Cat# 81038
Histone H3K4me1 Peptide - biotinylated Active Motif Cat# 81040
Histone H3K4me2 Peptide - biotinylated Active Motif Cat# 81041
Histone H3K4me3 Peptide - biotinylated Active Motif Cat# 81042
FANCD2 (human) Hiroshi Kimura; Sato et al.,
2012
N/A
Histone H3.1 - biotinylated Active Motif Cat# 31296
Histone H3K4me1 (EPL) - biotinylated Active Motif Cat# 31284
Critical Commercial Assays
Duolink In Situ Red Starter Kit
Mouse/Rabbit
Sigma-Aldrich Cat# DUO92101
SNAP-Cell Starter Kit NEB Cat# E9100S
Deposited Data
Pre-deposited iPOND mass spectrometry
data
Dungrawala et al., 2015 N/A
Experimental Models: Cell Lines
HeLa-H3.1-GFP (WT and K4A) Hiroshi Kimura; Sato et al.,
2012
N/A
HeLa ATCC Cat# CCL-2
U-2-OS ATCC Cat# HTB-96
U-2-OS Flp-In TRex Stephen Taylor (University of
Manchester)
N/A
A549 ATCC Cat# CCL-185
DT40s (WT and FANCD2 variants) Minoru Takata; Sato et al.,
2012
N/A
Oligonucleotides
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SETD1A siRNA (3′ UTR) QIAGEN Cat# SI05029045
SETD1A siRNA (SmartPool; SP) Dharmacon Cat# L-022793-01-0010
BOD1L siRNA (SP) Dharmacon Cat# L-017033-02-0005
FANCD2 siRNA (SP) Dharmacon Cat# J-016376-05-0005
FBH1 siRNA (SP) Dharmacon Cat# J-017404-05-0005
BLM siRNA (SP) Dharmacon Cat# J-007287-06-0005
BOD1 siRNA (SP) Dharmacon Cat# L-015526-02-0005
SETD1B siRNA (SP) Dharmacon Cat# J-027025-09-0005
CHD1 siRNA (SP) Dharmacon Cat# J-008529-05-0005
CHD4 siRNA (SP) Dharmacon Cat# L-009774-00-0005
KMT2B (MLL2) siRNA (SP) Dharmacon Cat# L-009670-00-0005
KMT2C (MLL3) siRNA (SP) Dharmacon Cat# L-007039-00-0005
BRCA2 siRNA (SP) Dharmacon Cat# L-003462-00-0005
MRE11 siRNA (SP) Dharmacon Cat# L-009271-00-0005
Cyclin K siRNA (SP) Dharmacon Cat# L-029590-00-0005
Control siRNA (luciferase)
(CGUACGCGG
AAUACUUCGdTdT)
Dharmacon Cat# CTM-334043
Control siRNA (Negative Control Hi GC) Life Technologies Cat# 10317903
BOD1L F1 Fwd (TATCCTGTCGACATGG
CCACCAACCCACAGCCGCAG)
Sigma-Aldrich N/A
BOD1L F1 Rev (CGAGTTAGCGGCCGG
GGTTTCTTTGGAATCTTCTTCATA)
Sigma-Aldrich N/A
BOD1L F2 Fwd
(CACGACGTCGACGAAA
AAGAAGAGAGGCTTTTAAGA)
Sigma-Aldrich N/A
BOD1L F2 Rev
(CGTTTGAGGGGCCGCT
TTCTCCTTTGCTAATGGTAACTT)
Sigma-Aldrich N/A
Recombinant DNA
pGEX-3x-BOD1L F1 (aa 1-600 of
BOD1L)
This paper N/A
pGEX-3x-BOD1L F2 (aa 500-1000 of
BOD1L)
This paper N/A
pSNAPm-H3.1 Geneviève Almouzni; Adam
et al., 2013
N/A
Software and Algorithms
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ImageJ NIH RRID: SCR_003070
David Bioinformatics Resources 6.8 NIAID/NIH https://david.ncifcrf.gov/; RRID:
SCR_001881
Nikon Elements (v.4.5) Nikon RRID: SCR_014329
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